🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is an open-label pilot study in newly diagnosed glioblastoma pati...
Status
Terminated
Location
University of California San Francisco
Start Date
2019-12-02
Trial ID
NCT03705351
Treatments Being Tested
The study is a prospective, single arm, non-randomized, open label pilot tr...
Status
Unknown
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02244502
Treatments Being Tested
This research study is for Glioblastoma (GBM) patients who will be beginnin...
Status
Recruiting
Location
Abramson Cancer Center
Start Date
2023-01-15
Trial ID
NCT05086497
Treatments Being Tested
The purpose of this post-authorisation medical device study is to obtain re...
Status
Recruiting
Location
Lungenklinik Gauting
Start Date
2023-08-01
Trial ID
NCT05538806
Treatments Being Tested
To test the effectiveness and safety of Optune® given concomitantly with ra...
Status
Completed
Location
Grandview Cancer Center
Start Date
2020-12-08
Trial ID
NCT04471844
Treatments Being Tested
This non-interventional study aims to investigate change over time in cogni...
Status
Unknown
Location
Universitätsklinikum Aachen
Start Date
2021-12-30
Trial ID
NCT04717739
Treatments Being Tested
The purpose of the study is to assess timing of TTFields use as well as saf...
Status
Withdrawn
Location
University Hospital of Heidelberg, Radiation Oncology
Start Date
2023-08-01
Trial ID
NCT04218019
Treatments Being Tested
The study is a prospective, single arm, non-randomized, open label phase II...
Status
Completed
Location
Antwerp University Hospital, Thoracic Oncology
Start Date
2015-02
Trial ID
NCT02397928
Treatments Being Tested
This will be a prospective, open label, single center, phase I lead-in stud...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT05973903
Treatments Being Tested
The study is a prospective, randomized controlled phase III trial aimed to ...
Status
Completed
Location
Central Alabama Research
Start Date
2016-12
Trial ID
NCT02973789
Treatments Being Tested